Vyant Bio Inc. sell Global_Player
Start price
30.03.22
/
50%
€8.50
Target price
30.03.23
-
Performance (%)
-24.12%
End price
31.03.22
€6.45
Summary
This prediction ended on 31.03.22 with a price of €6.45. The prediction for Vyant Bio Inc. closed with a convincing performance of -24.12%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
According to Global_Player what are the pros and cons of Vyant Bio Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Cancer Genetics Inc. diskutieren
Sell Vyant Bio Inc.